Facial redness in Japanese adolescents with atopic dermatitis treated with dupilumab: A case series

Shuhei Hara, MD; Takaaki Itonaga, MD; Makoto Nishino, MD; Noriyuki Yanagida, MD, PhD; Sakura Sato, MD; Motohiro Ebisawa, MD, PhD

Journal of Allergy and Clinical Immunology: Global (May 2023)

Facial redness in Japanese adolescents with atopic dermatitis treated with dupilumab: A case series

Shuhei Hara, MD,
Takaaki Itonaga, MD,
Makoto Nishino, MD,
Noriyuki Yanagida, MD, PhD,
Sakura Sato, MD,
Motohiro Ebisawa, MD, PhD

Affiliations

Shuhei Hara, MD: Department of Pediatrics and, Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan
Takaaki Itonaga, MD: Department of Pediatrics and, Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan
Makoto Nishino, MD: Department of Allergy, Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan
Noriyuki Yanagida, MD, PhD: Department of Pediatrics and, Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan; Department of Allergy, Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan; Corresponding author: Noriyuki Yanagida, MD, PhD, Department of Pediatrics, National Hospital Organization Sagamihara National Hospital, 18-1 Sakuradai, Minami-ku, Sagamihara, Kanagawa 252-0392, Japan.
Sakura Sato, MD: Department of Pediatrics and, Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan; Department of Allergy, Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan
Motohiro Ebisawa, MD, PhD: Department of Pediatrics and, Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan; Department of Allergy, Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan

Journal volume & issue: Vol. 2, no. 2
p. 100096

Abstract

Read online

This case series study is the first report of Japanese adolescents who experienced dupilumab facial redness after starting dupilumab treatment for refractory atopic dermatitis. In every case, dupilumab facial redness subsided without discontinuation of dupilumab within 3 months after onset.

Published in Journal of Allergy and Clinical Immunology: Global

ISSN: 2772-8293 (Online)
Publisher: Elsevier
Country of publisher: United States
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
Website: https://www.sciencedirect.com/journal/journal-of-allergy-and-clinical-immunology-global

About the journal

Abstract

Keywords